|
|
RETINA READ RISK |
|
The
Innovation project "Retina-Read-Risk", supported by EIT
Health, begun officially in February 2022.
The consortium is composed
of :
The Fundaciķ
Institut d'Investigaciķ Sanitāria Pere Virgili (IISPV) who
leads the project
lnstitut Catalā
de la Salut (ICS)
Telefonica
Grupo TRC
GENESIS Biome
E-SENIORS
lFondation de l'Avenir
Diabetic
retinopathy (DR) is a microvascular complication of type 1 and type 2 diabetes
that affects the small vessels of the retina. DR can lead to total vision
loss if not detected early, and is the leading cause of preventable blindness
in working-age adults.
With RetinaReadRisk, we are developing a new platform for the
early detection and diagnosis of DR in rural areas. It combines models of
artificial intelligence and 5G technologies that would enable image capture in
doctors' surgeries closest to the population via a smartphone. This image
capture can then be analyzed automatically, helping to predict the risk of a
person developing DR.
The
solution is the result of a European project funded by the EIT Health with a
consortium of 7 partners: the Institut d'Investigaciķ Sanitāria Pere Virgili, the Institut Catalā de la Salut, GENESIS Biomed ,
Telefķnica SA, Grupo TRC, Fondation de l'Avenir and E-Seniors.
Press release 14thof March 2022